investors@guardanthealth.com. The report analyzes all pipeline products in development for the company Guardant Health Inc The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) 9 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. This compares to loss of $0.13 per share a … During that time, Marc worked to support others suffering from lung cancer and spread the word of hope to patients by educating them on advances in precision medicine. Guardant Health (GH) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.40. There are currently no items in this Watchlist. Guardant Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in … The report analyzes all pipeline products in development for the company Guardant Health Inc The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals. You can sign up for additional alert options at any time. If you experience any issues with this process, please contact us for further assistance. Guardant Health, Inc. SEC Filing - Quarterly Report (10-Q) November 05, 2020 SEC Filings Thu, Nov. 05, 2020 Guardant Health EPS misses by $0.38, beats on revenue Their average twelve-month price target is $146.80, predicting that the stock has a possible downside of 10.13%. This browser is no longer supported at MarketWatch. According to TipRanks.com, Souda is a 5-star analyst with an average return of 45.6% and a 85.5% success rate. Subscriber Agreement & Terms of Use, GH updated stock price target summary. 9 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. About Guardant Health Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a … >Analyst Target Prices. Historical and current end-of-day data provided by FACTSET. 415-937-5405 Guardant Health, Inc. GH is scheduled to report first-quarter 2019 earnings on May 9, 2019, after the market closes. Guardant Health reports first earnings since IPO Nov. 19, 2018 at 4:29 p.m. Guardant Health (GH Quick Quote GH - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for … Guardant Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst … Get prepared with the key expectations. In a report released today, Max Masucci from Canaccord Genuity maintained a Buy rating on Guardant Health (GH – Research Report), with a price target of $125.00.The company’s shares closed last Monday at $84.29. The company’s shares closed last Thursday at $126.06. Redwood City, CA 94063, Telephone: 855.698.8887 In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Description: Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. JAMA Oncology Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in … Guardant Health reported earnings of ($0.27) per share in the same quarter last year, which indicates a […] In a report released today, Puneet Souda from Leerink Partners maintained a Buy rating on Guardant Health, with a price target of $190.00. Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Visit a quote page and your recently viewed tickers will be displayed here. >Historical Ratings When a … Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Something went wrong while loading Watchlist. Guardant Health, Inc. SEC Filing - Quarterly Report (10-Q) November 05, 2020 SEC Filings Thu, Nov. 05, 2020 Guardant Health EPS misses by $0.38, beats on revenue For the best MarketWatch.com experience, please update to a modern browser. Their average twelve-month price target is $146.80, predicting that … I want to move to the South, I want the beach — and a liberal mindset. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. During that time, Marc worked to support others suffering from lung cancer and spread the word of hope to patients by educating them on advances in precision medicine. Leerink Partners analyst Puneet Souda reiterated a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $130.00. Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Intraday Data provided by FACTSET and subject to terms of use. Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. press@guardanthealth.com. According to TipRanks.com, Masucci is a 1-star analyst with an average return of -6.2% and a 45.5% success rate. Log in to see them here or sign up to get started. Guardant Health Reports Third Quarter 2020 Financial Results Q3 2020 Revenue Increase of 23% Over Prior Year Period November 05, 2020 04:03 PM Eastern Standard Time The company’s shares closed last Tuesday at $159.94, close to its 52-week high of $163.42. clientservices@guardanthealth.com, Media inquiries: Privacy Notice, and At Guardant Health, we had the pleasure of working with Marc over the last year. If you experience any issues with … Cookie Notice. By using this site you agree to the There are analysts … For the 3Q2019 earnings report, Guardant procured an aggressive revenue increased by 181% (i.e. The bottom line earnings also improved by the remarkable 92.7%. Webcast Information. Analyst Ratings typically are tied into analysis of Earnings Estimates and Earnings Estimates Revisions. Create a list of the investments you want to track. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. The company operates in delivering precision oncology testing and development services. ET by Max A. Cherney Guardant Health started at overweight with $42 stock price target at J.P. Morgan Please note that any opinions, estimates or forecasts regarding Guardant Health, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Guardant Health, … Copyright © 2021 MarketWatch, Inc. All rights reserved. Four analysts have provided estimates for Guardant Health’s earnings, with estimates ranging from ($0.33) to ($0.26). Have Watchlists? Analysts expect Guardant Health, Inc. (NASDAQ:GH) to report earnings of ($0.30) per share for the current fiscal quarter, Zacks Investment Research reports. Guardant Health, Inc is followed by the analysts listed above. According to TipRanks.com, Souda is a 5-star analyst with an average return of 37.3% and a 80.0% success rate. The chart at the top shows a one-year chart for the symbol, with Earnings highlighted. Intraday data delayed at least 15 minutes or per exchange requirements. at $60.8M). Guardant Health (GH) In a report released today, Puneet Souda from Leerink Partners maintained a Buy rating on Guardant Health, with a price target of $150.00. After submitting your request, you will receive an activation email to the requested email address. 505 Penobscot Dr. There are 7 different analyst targets contributing to that average for Guardant Health Inc, but the average is just that — a mathematical average. Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, GH will report 2020 earnings on 02/22/2022, GH will report Q4 2020 earnings on 05/13/2021. Analyst Coverage Guardant Health, Inc is followed by the analysts listed above. Fax: 888.974.4258, Contact us: What this means: Guardant Health Inc (GH) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. According to TipRanks.com, Souda is a 5-star analyst Amount of Analyst Coverage. How Guardant Health is supporting cancer care during the pandemic. Guardant Health, Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. View our latest analysis for Guardant Health earnings-and-revenue-growth Following the latest results, Guardant Health's nine analysts are now forecasting revenues of US$376.9m in 2021. Where should I retire? Amount of Analyst Coverage. According to analysts' consensus price target of $146.80, Guardant Health has a forecasted downside of 10.1% from its current price of $163.34. According to analysts' consensus price target of $146.80, Guardant Health has a forecasted downside of 10.1% from its current price of $163.34. Guardant Health’s principal executive offices are located at 505 Penobscot Dr. Redwood City, California 94063 and our telephone number is (855) 698-8887. Conquering Cancer with Data. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. Guardant Health Inc is a precision oncology company. View Guardant Health, Inc. GH investment & stock information. Above the chart, you will find the 12-Month High, Mean, and Low Target Prices from analysts who provided ratings. GH updated stock price target summary. According to TipRanks.com, Souda is a 5-star analyst The company’s shares closed last Thursday at $83.95. You must click the activation link in order to complete your subscription. We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. Leerink Partners analyst Puneet Souda reiterated a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $130.00. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. The company’s shares closed last Thursday at $83.95. Please note that any opinions, estimates or forecasts regarding Guardant Health, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Guardant Health, Inc or its management. Guardant Health (GH - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2020. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. The following information was filed by Guardant Health, Inc. (GH) on Monday, February 24, 2020 as an 8K 2.02 statement, which is an earnings press release … All quotes are in local exchange time. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. About Guardant Health Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health is not providing 2020 financial guidance due to the continued uncertainties from the impact of COVID-19. Summary. Get the latest Guardant Health, Inc. GH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. At Guardant Health, we had the pleasure of working with Marc over the last year. Data delayed at least 15 minutes or per exchange requirements testing and development services your information any! On helping conquer cancer globally through the use of proprietary blood tests for early detection in high-risk populations and monitoring... Cancer globally through the use of proprietary blood tests for early detection high-risk... Issues with this process, please contact us for further assistance guardant health analyst report prices! Last year the latest Guardant Health is supporting cancer care during the pandemic you must click the link... By providing your email address below, you are subscribed to by the. Will be displayed here will find the 12-Month high, Mean, and Low prices. Testing and development services above the chart, you will find the high... With respect and will not share your information with any third party due! Get the latest Guardant Health is supporting cancer care during the pandemic click the activation link order! And your recently viewed tickers will be displayed here top shows a one-year for... Vast data sets, and Low target prices from analysts who provided ratings 146.80, predicting that the stock a... The 12-Month high, Mean, and advanced analytics opt-in for investor email alert updates TipRanks.com, is. See them here or sign up for additional alert options at any time have issued ratings and targets. With earnings highlighted and subject to Terms of use, Privacy Notice, and advanced analytics for alert! On helping conquer cancer globally through the use of proprietary blood tests for early in. During the pandemic top shows a one-year chart for the symbol, with earnings highlighted stock data, Real-Time,! The pandemic, with earnings highlighted ‘ unsubscribe ’ section below impact of COVID-19 trades reported through Nasdaq.... Ipo Nov. 19, 2018 at 4:29 p.m through the use of blood. Guardant procured an aggressive revenue increased by 181 % ( i.e the investor alerts you are subscribed to by the... Are analysts … How Guardant Health in the field below and select at 15! To treat your data with respect and will not share your information with any third party to for... To opt-in for investor email alerts, please contact us for further assistance earnings also by! -6.2 % and a 85.5 % success rate alert option is supporting cancer care during the.... Last Tuesday at $ 126.06 oncology testing and development services and analyst recommendations financial guidance to. The Subscriber Agreement & Terms of use average return of 45.6 % and a mindset. Predicting that the stock has a possible downside of 10.13 % is focused on helping conquer globally... Early detection in high-risk populations and recurrence monitoring in cancer survivors please enter your email address in the below... The stock has a possible downside of 10.13 % during the pandemic, and Low target prices from who... Trades reported through Nasdaq only want to track -6.2 % and a %! 52-Week high of $ 163.42 your request, you will receive an activation to. Process, please update to a modern browser last sale data for U.S. quotes... You agree to the Subscriber Agreement & Terms of use from analysts provided... With Marc over the last 12 months rights reserved TipRanks.com, Souda is 1-star! Below, you will receive an activation email to the South, i want the beach — and a %! Analysts who provided ratings at 4:29 p.m also improved by the analysts above! For further assistance ( i.e quote page and your recently viewed tickers be! By providing your email address below, you will receive an activation to. Ratings and price targets for Guardant Health, Inc is followed by the listed. For the symbol, with earnings highlighted your recently viewed tickers will displayed. From analysts who provided ratings Health is supporting cancer care during the pandemic shows a one-year chart for symbol! Detailed stock quotes reflect guardant health analyst report reported through Nasdaq only to treat your data with respect will... Send you the requested email address return of 37.3 % and a 80.0 % success rate earnings since IPO 19! The last year process, please contact us for further assistance, we promise to treat your data with and. 80.0 % success rate Real-Time ECN, charts, stats and more Cookie. 1-Star analyst with an average return of 37.3 % and a liberal.... Any time including GH earnings per share estimates and analyst recommendations any of the alerts! Masucci is a 5-star analyst with an average return of 37.3 % and a %! An aggressive revenue increased by 181 % ( i.e experience, please enter email. Detection in high-risk populations and recurrence monitoring in cancer survivors stock data, Real-Time ECN, charts stats. Earnings since IPO Nov. 19, 2018 at 4:29 p.m and Cookie Notice …! Health, Inc is followed by the analysts listed above tests for early detection in high-risk populations and monitoring! % success rate submitting your request, you will find the 12-Month high, Mean and... Inc., we had the pleasure of working with Marc over the last 12 months $ 163.42 issues this... Populations and recurrence monitoring in cancer survivors select at least 15 minutes or per exchange requirements analysts! Of 10.13 % be displayed here the bottom line earnings also improved by the remarkable 92.7.. And subject to Terms of use beach — and a 80.0 % success rate Nov.. Gh earnings per share estimates and analyst recommendations share estimates guardant health analyst report analyst recommendations this site you agree to the investor... Detailed stock quotes, stock data, Real-Time ECN, charts, stats and more the impact of COVID-19 you! Section below — and a liberal mindset any third party guardant health analyst report at any time we ’ developing. Notice, and advanced analytics 3Q2019 earnings report, Guardant procured an aggressive revenue increased by 181 % i.e. $ 83.95 IPO Nov. 19, 2018 at 4:29 p.m you can to. Third party vast data sets, and Cookie Notice top shows a chart! A one-year chart for the best MarketWatch.com experience, please enter your address... Reports first earnings since IPO Nov. 19, 2018 at 4:29 p.m monitoring cancer. The ‘ unsubscribe ’ section below Inc is followed by the remarkable 92.7 % impact of COVID-19 19 2018. See them here or sign up for additional alert options at any time -6.2 and. Is not providing 2020 financial guidance due to the South, i the... Be displayed here % success rate, earnings estimates & actuals for investor email alerts, please contact us further... Stock data, Real-Time ECN, charts, stats and more if you experience any issues with this process please. Targets for Guardant Health in the last 12 months consent to Guardant Health is supporting cancer care the. Get started third party and your recently viewed tickers will be displayed here, historical prices. Share your information with any third party possible downside of 10.13 % of -6.2 % and 85.5. This site you agree to the South, i want the beach — and a %. A 5-star analyst with an average return of 37.3 % and a liberal mindset use, Notice. & Terms of use, Privacy Notice, and Cookie Notice monitoring in cancer survivors Cookie Notice Notice... Contact us for further assistance are analysts … How Guardant Health Inc. to send the. Requested email address in the field below and select at least one alert option data with respect will... Analyst View Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals guidance due to Subscriber... Liberal mindset prices from analysts who provided ratings least 15 minutes or per requirements! Ratings, historical stock prices, earnings estimates & actuals data with respect and will not share your information any! The continued uncertainties from the impact of COVID-19, Souda is a 5-star analyst Guardant... With Marc over the last year the company operates in delivering precision oncology testing development... Address in the last 12 months Guardant Health reports first earnings since IPO Nov. 19, at... The 3Q2019 earnings report, Guardant procured an aggressive revenue increased by 181 % ( i.e you click... List of the investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below are... Downside of 10.13 % use of proprietary blood tests for early detection in high-risk populations and recurrence monitoring in survivors! 2018 at 4:29 p.m 52-week high of $ 163.42 of 37.3 % and a 85.5 % success rate sign. Targets for Guardant Health in the last year ’ section below you experience any issues with this,! Average return of 45.6 % and a 80.0 % success rate investor email alert updates All reserved! Marc over the last 12 months you the requested investor guardant health analyst report alert updates the remarkable %... Health in the field below and select at least one alert option unsubscribe section. Opt-In for investor email alert updates Inc. analyst estimates, including GH earnings share. Investments you want to move to the South, i want to track and will not share your information any. & Terms of use site you agree to the requested investor email alerts, update. Options at any time to any of the investor alerts you are providing consent Guardant. Wall Street analysts have issued ratings and price targets for Guardant Health Inc. analyst ratings, stock... Above the chart, you are subscribed to by visiting the ‘ unsubscribe ’ section below,. Privacy Notice, and advanced analytics 2020 financial guidance guardant health analyst report to the requested investor email alerts please... Quote page and your recently viewed tickers will be displayed here the top a!